Inflammatory Cytokine Blockade – Definition & Effects
Inflammatory cytokine blockade is a targeted therapy that inhibits pro-inflammatory signaling proteins (cytokines) to suppress excessive or misdirected immune responses.
Things worth knowing about "Inflammatory cytokine blockade"
Inflammatory cytokine blockade is a targeted therapy that inhibits pro-inflammatory signaling proteins (cytokines) to suppress excessive or misdirected immune responses.
What is Inflammatory Cytokine Blockade?
Inflammatory cytokine blockade refers to a medical strategy in which specific pro-inflammatory signaling proteins of the immune system – known as cytokines – are selectively inhibited or blocked. Cytokines are proteins secreted by immune cells that regulate communication between cells and coordinate the immune response. In chronic inflammatory diseases or conditions involving an overactive immune system, certain cytokines can be produced in excessive amounts, leading to tissue damage. Cytokine blockade directly targets this process.
Mechanism of Action
Cytokine blockade is primarily achieved through biologic medications (biologics), including monoclonal antibodies and soluble receptor proteins. These agents bind specifically to individual cytokines or their receptors, thereby preventing their pro-inflammatory effects. The most important target molecules include:
- TNF-alpha (Tumor Necrosis Factor-alpha): A key inflammatory cytokine involved in conditions such as rheumatoid arthritis and Crohn's disease. Inhibitors include adalimumab, etanercept, and infliximab.
- Interleukin-6 (IL-6): Promotes systemic inflammatory responses and is elevated in rheumatoid arthritis and severe COVID-19. Inhibitors include tocilizumab and sarilumab.
- Interleukin-1 (IL-1): Plays a role in fever responses and autoinflammatory diseases. Inhibitors include anakinra and canakinumab.
- Interleukin-17 (IL-17): Central to psoriasis and ankylosing spondylitis. Inhibitors include secukinumab and ixekizumab.
- Interleukin-23 (IL-23): Important in psoriasis and inflammatory bowel disease. Inhibitors include guselkumab and risankizumab.
Indications
Inflammatory cytokine blockade is used in a wide range of diseases where an excessive or misdirected immune response plays a central role:
- Rheumatoid arthritis: chronic joint inflammation
- Crohn's disease and ulcerative colitis: chronic inflammatory bowel diseases
- Psoriasis and psoriatic arthritis: skin and joint inflammation
- Ankylosing spondylitis: chronic spinal inflammation
- Systemic lupus erythematosus: autoimmune disease with organ involvement
- Cytokine storm: life-threatening excessive immune response, e.g., in severe infections or following immunotherapy
Administration and Dosage
Biologics used for cytokine blockade are typically administered as a subcutaneous injection (under the skin) or as an intravenous infusion. The exact dosage and treatment schedule depend on the specific medication, the disease being treated, and the individual response of the patient. Treatment is always supervised by specialist physicians such as rheumatologists or gastroenterologists.
Side Effects and Risks
Because cytokine blockade selectively suppresses parts of the immune system, the following risks may occur:
- Increased susceptibility to infections: particularly bacterial infections, tuberculosis, and opportunistic pathogens
- Reactivation of latent infections: such as tuberculosis or hepatitis B
- Injection or infusion reactions: local skin reactions or general hypersensitivity responses
- Increased risk of certain cancers: with long-term therapy (particularly lymphomas, in rare cases)
- Worsening of heart failure: with certain TNF blockers
Before starting therapy, screening tests for latent infections are typically performed. Regular medical check-ups are required throughout the course of treatment.
Importance in Modern Medicine
Inflammatory cytokine blockade has revolutionized the treatment of many chronic inflammatory diseases. For patients in whom conventional therapies such as corticosteroids or disease-modifying antirheumatic drugs (DMARDs) are insufficiently effective, biologics often provide a significant improvement in quality of life and durably slow disease progression.
References
- Smolen JS et al. - Rheumatoid arthritis. Nature Reviews Disease Primers, 2018. DOI: 10.1038/nrdp.2018.1
- Dinarello CA - Overview of the IL-1 family in innate inflammation and acquired immunity. Immunological Reviews, 2018. DOI: 10.1111/imr.12621
- World Health Organization (WHO) - Biologicals: Monoclonal Antibodies. Available at: https://www.who.int/biologicals/monoclonal_antibodies/en/
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryRegulating cortisol naturally
Quercetin bioavailability markers
Magnesium bisglycinate therapy
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Inflammatory cytokine blockade